242 related articles for article (PubMed ID: 32397905)
1. Rhabdomyolysis and acute kidney injury induced by the association of rosuvastatin and abiraterone: A case report and review of the literature.
Ould-Nana I; Cillis M; Gizzi M; Gillion V; Hantson P; Gérard L
J Oncol Pharm Pract; 2021 Jan; 27(1):216-219. PubMed ID: 32397905
[TBL] [Abstract][Full Text] [Related]
2. Abiraterone-induced rhabdomyolysis resulting in acute kidney injury: A case report and review of the literature.
Dineen M; Hansen E; Guancial E; Sievert L; Sahasrabudhe D
J Oncol Pharm Pract; 2018 Jun; 24(4):314-318. PubMed ID: 28355968
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyolysis-induced acute kidney injury in a cancer patient exposed to denosumab and abiraterone: a case report.
Neyra JA; Rocha NA; Bhargava R; Vaidya OU; Hendricks AR; Rodan AR
BMC Nephrol; 2015 Jul; 16():118. PubMed ID: 26220655
[TBL] [Abstract][Full Text] [Related]
4. Acute renal failure due to rhabdomyolysis in relation to abiraterone and rosuvastatin.
Cintra M; Pedraza Cezón LA; Martín Navarro JA; Torres Aguilera E; Albalate Ramón M; Alcázar Arroyo R; Procaccini F; Puerta Carretero M; Ortega Díaz M; Medina Zahonero L; Jaldo Rodríguez MT; de Sequera P
Nefrologia (Engl Ed); 2023; 43(3):374-376. PubMed ID: 37500306
[No Abstract] [Full Text] [Related]
5. Abiraterone-induced rhabdomyolysis: A case report.
Moore DC; Moore A
J Oncol Pharm Pract; 2017 Mar; 23(2):148-151. PubMed ID: 26637407
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of abiraterone acetate plus prednisolone in patients with early metastatic castration-resistant prostate cancer who failed first-line androgen-deprivation therapy: a single-arm, phase 4 study.
Kobayashi K; Okuno N; Arai G; Nakatsu H; Maniwa A; Kamiya N; Satoh T; Kikukawa H; Nasu Y; Uemura H; Nakashima T; Mikami K; Iinuma M; Tanabe K; Furukawa J; Kobayashi H
Jpn J Clin Oncol; 2021 Apr; 51(4):544-551. PubMed ID: 33324967
[TBL] [Abstract][Full Text] [Related]
7. Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcome.
Colomba E; Marret G; Baciarello G; Lavaud P; Massard C; Loriot Y; Albiges L; Carton E; Alexandre J; Huillard O; Culine S; Fizazi K
Eur J Cancer; 2020 Apr; 129():117-122. PubMed ID: 32151941
[TBL] [Abstract][Full Text] [Related]
8. Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein-mediated drug interaction?
Lehtisalo M; Kiander W; Filppula AM; Deng F; Kidron H; Korhonen M; Sinkko J; Koivula K; Niemi M
Br J Clin Pharmacol; 2023 Jul; 89(7):2309-2315. PubMed ID: 36740817
[TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin-Induced Rhabdomyolysis - Possible Role of Ticagrelor and Patients' Pharmacogenetic Profile.
Vrkić Kirhmajer M; Macolić Šarinić V; Šimičević L; Ladić I; Putarek K; Banfić L; Božina N
Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):509-518. PubMed ID: 29734517
[TBL] [Abstract][Full Text] [Related]
10. Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report.
Wang W; Lu X; Li C; Teng W; Cui W
BMC Infect Dis; 2022 Apr; 22(1):365. PubMed ID: 35410138
[TBL] [Abstract][Full Text] [Related]
11. Acute kidney injury and rhabdomyolysis due to ticagrelor and rosuvastatin.
Parish LP; Cutshall T; Duhart B
Nurse Pract; 2021 Nov; 46(11):12-16. PubMed ID: 34695045
[No Abstract] [Full Text] [Related]
12. Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between cyclosporine, leflunomide, and rosuvastatin in a kidney transplant recipient: A missed opportunity for pharmacist involvement.
Korzec J; Strausbaugh R; Mikolay JJ; Churchwell MD
J Am Pharm Assoc (2003); 2024; 64(3):102016. PubMed ID: 38272309
[TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin-related rhabdomyolysis causing severe proximal paraparesis and acute kidney injury.
Hussain K; Xavier A
BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31601550
[TBL] [Abstract][Full Text] [Related]
14. Severe rhabdomyolysis induced by co-administration of cocaine and heroin in a 45 years old man treated with rosuvastatin: a case report.
Mitaritonno M; Lupo M; Greco I; Mazza A; Cervellin G
Acta Biomed; 2021 Apr; 92(S1):e2021089. PubMed ID: 33944852
[TBL] [Abstract][Full Text] [Related]
15. Study of cases of abiraterone discontinuation due to toxicity in pre-chemotherapy after 1 year's experience.
Ramudo-Cela L; Balea-Filgueiras J; Vizoso-Hermida JR; Martín-Herranz I
J Oncol Pharm Pract; 2017 Dec; 23(8):615-619. PubMed ID: 27753628
[TBL] [Abstract][Full Text] [Related]
16. A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer.
McKay RR; Werner L; Jacobus SJ; Jones A; Mostaghel EA; Marck BT; Choudhury AD; Pomerantz MM; Sweeney CJ; Slovin SF; Morris MJ; Kantoff PW; Taplin ME
Cancer; 2019 Feb; 125(4):524-532. PubMed ID: 30427533
[TBL] [Abstract][Full Text] [Related]
17. Renal Tubular Toxicity Associated With Rosuvastatin Therapy.
Ward FL; John R; Bargman JM; McQuillan RF
Am J Kidney Dis; 2017 Mar; 69(3):473-476. PubMed ID: 27856086
[TBL] [Abstract][Full Text] [Related]
18. Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy.
Francini E; Montagnani F; Nuzzo PV; Gonzalez-Velez M; Alimohamed NS; Rosellini P; Moreno-Candilejo I; Cigliola A; Rubio-Perez J; Crivelli F; Shaw GK; Zhang L; Petrioli R; Bengala C; Francini G; Garcia-Foncillas J; Sweeney CJ; Higano CS; Bryce AH; Harshman LC; Lee-Ying R; Heng DYC
JAMA Netw Open; 2021 Jul; 4(7):e2116536. PubMed ID: 34292336
[TBL] [Abstract][Full Text] [Related]
19. Abiraterone Acetate: A Review in Metastatic Castration-Resistant Prostrate Cancer.
Scott LJ
Drugs; 2017 Sep; 77(14):1565-1576. PubMed ID: 28819727
[TBL] [Abstract][Full Text] [Related]
20. Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4.
Li DQ; Kim R; McArthur E; Fleet JL; Bailey DG; Juurlink D; Shariff SZ; Gomes T; Mamdani M; Gandhi S; Dixon S; Garg AX
CMAJ; 2015 Feb; 187(3):174-180. PubMed ID: 25534598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
